Excessive Pricing in Pharmaceuticals

Oecd

No 273, OECD Roundtables on Competition Policy Papers from OECD Publishing

Abstract: This paper explores excessive prices at the intersection between competition law and regulated sectors such as pharma. It was prepared as a background note for the OECD Competition Committee roundtable on “Excessive pricing in pharmaceuticals”, which took place in November 2018.

Date: 2018-03-28
References: Add references at CitEc
Citations:

Downloads: (external link)
https://doi.org/10.1787/8e161f63-en (text/html)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:oec:dafaac:273-en

Access Statistics for this paper

More papers in OECD Roundtables on Competition Policy Papers from OECD Publishing Contact information at EDIRC.
Bibliographic data for series maintained by ().